Exclusive: Pangaea Data, AstraZeneca leverage AI to detect rare diseases
Exclusive: Pangaea Data, AstraZeneca leverage AI to detect rare diseases | MobiHealthNews
Skip to main content…
Continue ReadingExclusive: Pangaea Data, AstraZeneca leverage AI to detect rare diseases | MobiHealthNews
Skip to main content…
Continue ReadingWelcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s…
Continue ReadingPangaea Data, a company focused on detecting hard-to-diagnose diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for an…
Continue ReadingPangaea Data has been selected by Mental Health Research for Innovation Centre (M-RIC) for a strategic partnership that will see its AI-driven product be used to characterise mental health patients and discover new clinically…
Continue Reading